SMITH PATRICK F
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to SMITH PATRICK F. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CERT | PRESIDENT, DRUG DEV SOLUTIONS | Sale | 5,409 | $11.03 | $59,661 | Oct 7, 2024 |
| CERT | PRESIDENT, DRUG DEV SOLUTIONS | Tax Withholding | 1,742 | $10.99 | $19,145 | Oct 4, 2024 |
| CERT | PRESIDENT, DRUG DEV SOLUTIONS | Sale | 5,264 | $16.76 | $88,225 | Apr 2, 2024 |
| CERT | PRESIDENT, DRUG DEV SOLUTIONS | Tax Withholding | 2,690 | $17.88 | $48,097 | Apr 1, 2024 |
| CERT | PRESIDENT, DRUG DEV SOLUTIONS | Sale | 5,000 | $18.00 | $90,000 | Feb 20, 2024 |
| CERT | PRESIDENT, INTEGRATED DRUG DEV | Sale | 19,104 | $21.55 | $411,691 | Jun 5, 2023 |
| CERT | PRESIDENT, INTEGRATED DRUG DEV | Tax Withholding | 2,894 | $23.80 | $68,877 | Mar 31, 2023 |
| CERT | PRESIDENT, INTEGRATED DRUG DEV | Sale | 2,387 | $13.48 | $32,177 | Nov 9, 2022 |
| CERT | PRESIDENT, INTEGRATED DRUG DEV | Tax Withholding | 1,244 | $12.23 | $15,214 | Nov 1, 2022 |
| CERT | PRESIDENT, INTEGRATED DRUG DEV | Sale | 10,000 | $17.71 | $177,100 | Aug 16, 2022 |
| CERT | PRESIDENT, INTEGRATED DRUG DEV | Sale | 10,000 | $19.16 | $191,600 | Jun 8, 2022 |
| CERT | PRESIDENT, INTEGRATED DRUG DEV | Sale | 3,352 | $22.29 | $74,716 | Apr 1, 2022 |
| CERT | PRESIDENT, INTEGRATED DRUG DEV | Award / Grant | 3,631 | — | — | Nov 1, 2021 |